WHO ICTRP trial
Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly…
CTRI/2009/091/000827 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2009/091/000827 |
|---|---|
| Public title | Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status |
| Scientific title | Cilengitide for Subjects With Newly Diagnosed Glioblastoma Multiforme and Methylated MGMT Gene Promoter - A Multicenter, Open-Label, Controlled Phase III Study, Testing Cilengitide in Combination With Standard Treatment (Temozolomide With Concomitant Radiation Therapy, Followed by Temozolomide… |
| Primary sponsor | Merck KGaA |
| Secondary sponsors | Quintiles Research India Private Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Phase 3 |
| Countries | India;Argentina;Australia;Austria;Belgium;Brazil;Canada;Chile;Colombia;Czech Republic;France;Germany;Hong Kong;Hungary;Israel;Italy;Mexico;Netherlands;Poland;Republic of Korea;Serbia… |
| Conditions | Health Condition 1: null- Glioblastoma |
| Interventions | Intervention1: Cilengitide, Temozolomide & Radiotherapy: Cilengitide 2000mg i.v. twice weekly, Temozolomide & Radiotherapy Control Intervention1: Temozolomide & Radiotherapy: Subjects in the control group will receive 6 weeks of… |
| Registration date | Oct 14, 2009 |
| Target size | 504 |
| Secondary IDs | EMD 121974-011;NCT00689221 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: